Joseph Shulman
Chief Tech/Sci/R&D Officer at RHYTHM PHARMACEUTICALS, INC.
Net worth: 1 145 $ as of 29/04/2024
Joseph Shulman active positions
Companies | Position | Start | End |
---|---|---|---|
RHYTHM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 26/07/2020 | - |
Career history of Joseph Shulman
Former positions of Joseph Shulman
Companies | Position | Start | End |
---|---|---|---|
RA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30/06/2019 | 30/06/2020 |
NOVELION THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 31/08/2014 | 30/06/2019 |
Training of Joseph Shulman
Boston University | Masters Business Admin |
University of Miami | Undergraduate Degree |
Statistics
International
United States | 5 |
Canada | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Novelion Therapeutics, Inc.
Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Joseph Shulman
- Experience